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INTRODUCTION
Most Fibroblast growth factors (FGFs) have N-terminal signal
peptides and are secreted from cells, allowing binding to and
activation of their cell surface receptors (FGFRs). Studies in
vertebrates, as well as simpler invertebrate model systems, have
yielded valuable insights into the functions of this important gene
family in multiple biological processes (Huang and Stern, 2005;
Rottinger et al., 2008; Thisse and Thisse, 2005). In embryos, these
functions include mesoderm induction and patterning, cell growth,
migration and differentiation. Later functions include organ
formation and maintenance, neuronal differentiation and survival,
wound healing and malignant transformation (Chen and Deng,
2005; Coumoul and Deng, 2003; Eswarakumar et al., 2005). FGFs
often signal directionally across epithelial-mesenchymal boundaries
and exhibit diverse and dynamic patterns of expression that are both
spatially and temporally restricted. Tightly regulated expression is
one mechanism that helps to ensure the specificity of FGF signaling
through FGFRs. An additional level of specificity is most likely
imparted by their divergent amino acid sequences, resulting in
differential binding affinity for the FGFR, heparan sulfate
proteoglycan (HSPG)-interaction specificity (a co-factor involved
in FGF-FGFR interaction), and/or FGF ligand range of action (e.g.
diffusibility).
FGF and FGFR genes have been identified in organisms ranging
from the nematode and fly to mouse and human. There are two
FGFs and one FGFR in Caenorhabditis elegans, and three FGFs and
two FGFRs in Drosophila melanogaster, as compared with 24 FGFs
and four FGFRs (three of which exhibit alternative splicing) in
humans and mice (Birnbaum et al., 2005; Huang and Stern, 2005).
In vertebrates, over 100 potential FGF-FGFR complexes are
predicted (Zhang et al., 2006). Thus, the expectation is that with so
many combinations possible, tight regulation of FGF activity and
receptor specificity must exist to regulate signaling. Many FGF-
FGFR interactions have been studied in the vertebrate system, but
the genetic redundancy can make dissection of the functional
contribution of particular FGF-FGFR interactions challenging (e.g.
Mariani et al., 2008). Often, more than four ligands interact with a
particular FGFR isoform at any one time.
Drosophila is an excellent model system for studying FGF
signaling, especially now that it appears that the full repertoire of
FGF ligands and receptors has been identified (reviewed by Huang
and Stern, 2005). Relatively few FGF-FGFR interactions are
possible, with only three FGF ligands [Pyramus (Pyr), Thisbe (Ths)
and Branchless (Bnl)] and two FGF receptors [Heartless (Htl) and
Breathless (Btl)] (reviewed by Ornitz and Itoh, 2001; Szebenyi and
Fallon, 1999). The FGFR Btl, and its FGF ligand Bnl, control
tracheal branching in the embryo, mesoderm migration over male
genital discs, and air sac formation in the larva (Ahmad and Baker,
2002; Sato and Kornberg, 2002; Sutherland et al., 1996). The
preliminary function of the Htl FGFR is to control mesoderm
migration during gastrulation (Beiman et al., 1996; Gisselbrecht et
al., 1996; Shishido et al., 1997). Later in development, among other
functions, Htl is also required for the differentiation of cells that
form the heart and hindgut musculature (Michelson et al., 1998; San
Martin and Bate, 2001). The ligands for the Htl FGFR in Drosophila
had remained elusive, until pyr and ths were identified by genomic
screens (Stathopoulos et al., 2004; Gryzik and Muller, 2004). Pyr
and Ths share homology with the FGF8 family of vertebrate FGFs.
Genetic evidence suggests that this pair of invertebrate FGFs
functions through a single FGFR, Htl, to control cell migration and
differentiation, as a deficiency mutant that removes both ligands
phenocopies the htl mutant (Stathopoulos et al., 2004; Gryzik and
FGF ligands in Drosophila have distinct activities required to
support cell migration and differentiation
Snehalata Kadam, Amy McMahon, Phoebe Tzou and Angelike Stathopoulos*
Fibroblast growth factor (FGF) signaling controls a vast array of biological processes including cell differentiation and migration,
wound healing and malignancy. In vertebrates, FGF signaling is complex, with over 100 predicted FGF ligand-receptor
combinations. Drosophila melanogaster presents a simpler model system in which to study FGF signaling, with only three ligands
and two FGF receptors (FGFRs) identified. Here we analyze the specificity of FGFR [Heartless (Htl) and Breathless (Btl)] activation by
each of the FGF ligands [Pyramus (Pyr), Thisbe (Ths) and Branchless (Bnl)] in Drosophila. We confirm that both Pyr and Ths can
activate Htl, and that only Bnl can activate Btl. To examine the role of each ligand in supporting activation of the Htl FGFR, we
utilize genetic approaches that focus on the earliest stages of embryonic development. When pyr and ths are equivalently
expressed using the Gal4 system, these ligands support qualitatively different FGFR signaling responses. Both Pyr and Ths function
in a non-autonomous fashion to support mesoderm spreading during gastrulation, but Pyr exhibits a longer functional range. pyr
and ths single mutants exhibit defects in mesoderm spreading during gastrulation, yet only pyr mutants exhibit severe defects in
dorsal mesoderm specification. We demonstrate that the Drosophila FGFs have different activities and that cell migration and
differentiation have different ligand requirements. Furthermore, these FGF ligands are not regulated solely by differential
expression, but the sequences of these linked genes have evolved to serve different functions. We contend that inherent properties
of FGF ligands make them suitable to support specific FGF-dependent processes, and that FGF ligands are not always
interchangeable.
KEY WORDS: Cell migration and differentiation, Drosophila, FGF signaling, Ligand-receptor interactions
Development 136, 739-747 (2009) doi:10.1242/dev.027904
California Institute of Technology, Division of Biology MC114-96, 1200 East
California Boulevard, Pasadena, CA 91125, USA.
*Author for correspondence (e-mail: angelike@caltech.edu)
Accepted 30 December 2008 D
E
V
E
LO
P
M
E
N
T
 Development ePress online publication date 21 January 2009
740
Muller, 2004). Thus, Drosophila melanogaster provides a unique
opportunity within an invertebrate model system, amenable to
genetic approaches, to gain insights into why multiple FGF ligands
are utilized to activate the same receptor isoform, as is typically the
case in vertebrates.
A question in the FGF field is whether the specificity of receptor-
ligand interactions is accomplished through the differential
expression of ligands or through differences in the signaling
properties of the ligand proteins themselves. An impressive analysis
of all vertebrate FGF-FGFR interactions was recently completed, in
which the binding specificities of ligand-receptor interactions were
examined in tissue culture (Ornitz et al., 1996; Zhang et al., 2006).
Specificity of receptor-ligand interactions was demonstrated in this
system; however, how this relates to in vivo processes is, for the
most part, undetermined. Only a limited number of in vivo studies
have been conducted to analyze the function of particular FGF-
FGFR interactions (e.g. Rentzsch et al., 2008; Yang et al., 2002). In
this study, we examine the individual functions of the FGF ligands
Pyr and Ths in Drosophila in order to define whether these ligands
have distinct functions and/or function redundantly, and to gain
insights into why multiple ligands are typically involved in
activating a particular FGFR coordinately. We find that the regulated
expression of ligands and their divergent protein sequence both
contribute to the specificity of FGF-FGFR interactions.
MATERIALS AND METHODS
Fly stocks and genetic approaches
Unless otherwise noted, fly stocks were obtained from the Bloomington Stock
Center and were reared under standard conditions at 25°C. The genotype ‘wild
type’ refers to the yw genetic background. Df(2R)BSC25 has been described
(Stathopoulos et al., 2004). The Gal4 drivers zenVRE.Kr-Gal4 and sim-Gal4
were obtained from M. Frasch (University of Erlangen-Nuremberg, Germany)
and Stephen Crews (University of North Carolina, Chapel Hill, NC, USA),
respectively. Two PiggyBac insertion stocks were obtained from the Exelixis
Collection Stock Center at Harvard Medical School (Thibault et al., 2004); we
determined that P02915 is located in the first intron of pyr, and confirmed that
P02026 is located in the second intron of ths.
Df(2R)ths238 is a deletion of the ths gene that was created in the course
of this study through a genetic screen for male-specific recombination (see
Preston et al., 1996) using P9.1.2, a viable P-element insertion located
~400 bp upstream from the ths transcription start site, as mapped by RACE
(see Fig. 2A). Line P9.1.2 resulted from mobilization of P10004, a viable
insertion located ~900 bp upstream from the ths transcription start site, to
remove 500 bp of ths upstream sequence. Deletion breakpoints were
confirmed using inverse PCR, in the case that the P-element was retained
[i.e. Df(2R)BSC25 and Df(2R)ths238].
Df(2R)pyr36 is a deletion of the pyr gene that was created by mobilization
of the P9.1.2 insertion and screening for excision events. The breakpoints of
this deficiency were mapped by complementation using available zygotic
lethal insertions (including walEY09961 and walk14026); we contend that the
Df(2R)pyr36 does not extend past the walrus (wal) and ths genes. The
500 bp of ths upstream sequence that was removed in the creation of line
P9.1.2 is also absent from Df(2R)pyr36. Yet, ths transcript levels and
domains of expression appear similar to those of the wild type in
Df(2R)pyr36/Df(2R)pyr36 mutant embryos (expression up to stage 15 was
examined; see Fig. 2F and data not shown). It is formally possible that cis-
regulatory sequences controlling expression at later stages were removed.
However, as the phenotypes exhibited by Df(2R)pyr36 are subtle relative to
Df(2R)BSC25, and as the FGF-homologous portion of Ths is located at its
N-terminus, it is likely that Df(2R)pyr36 does not remove ths coding
sequence.
UAS-bnl and UAS-ths have been described previously (Stathopoulos et
al., 2004; Sutherland et al., 1996). UAS-pyr was generated during the course
of this work. No EST is available for pyr. Therefore, the 5 and 3 ends of
the pyr gene were determined by RACE (Stathopoulos et al., 2004). Primers
based on this sequence were used to PCR amplify the intact pyr gene. PCR
of the intact full-length gene from the RACE cDNA with a single primer pair
was not possible, probably owing to repeats within the gene. Instead, two
separate PCR reactions were performed to isolate sequence spanning the
full-length gene (one to amplify the 5end from cDNA and the other to
obtain sequence corresponding to the last exon from genomic DNA). The
two products were ligated in a three-way ligation to reconstitute the full-
length pyr coding sequence.
UAS-pyr and UAS-ths fly stocks were constructed using standard
methods (Spralding and Rubin, 1982). For the genetic rescue experiments,
virgins of the following genetic backgrounds (#1) Df(2R)BSC25 sim-
Gal4/CyO ftz-lacZ, (#2) Df(2R)BSC25/CyO wg-lacZ; zenVRE.Kr-Gal4 and
(#3) Df(2R)BSC25/CyO wg-lacZ; 69B-Gal4 were crossed with males from
(#4) Df(2R)BSC25/CyO wg-lacZ; UAS-pyr, (#5) Df(2R)BSC25/CyO wg-
lacZ; UAS-ths, (#6) Df(2R)BSC25/CyO wg-lacZ; UAS-bnl, (#7)
Df(2R)BSC25/CyO ftz-lacZ; UAS-pyr, (#8) Df(2R)BSC25/CyO ftz-lacZ;
UAS-ths or (#9) Df(2R)BSC25/CyO ftz-lacZ; UAS-bnl.
Quantitative PCR
Embryos were manually separated and flash frozen using liquid nitrogen.
Three biological replicates of each sample (i.e. 20 dechorionated embryos
of stage 9/10) were obtained. Total RNA isolation was carried out using
the RNeasy Micro Kit (Qiagen) and quantified using a ND-1000
spectrophotometer (NanoDrop Technologies). One microgram of total RNA
was used for reverse transcription to synthesize cDNA using the Gene Racer
Superscript III RT Module Kit (Invitrogen). The quantitative PCR (qPCR)
reaction was performed in 96-well format using LightCycler SYBR Green
480 (Roche). The qPCR was set up as follows: 95°C for 5 minutes; 35 cycles
of 95°C for 20 seconds, 55°C for 20 seconds, and 72°C for 30 seconds; and
a final 72°C for 10 minutes. For quantifying the transcript levels in
ectopically expressing pyr and ths lines, the data were normalized to the
transcript level of a housekeeping gene, Elongation factor 1 (Ishimoto et al.,
2005). In order to quantify the levels of ‘ectopic’ pyr and ths expression
supported by the Gal4 driver and transgenes containing UAS, we used twist-
Gal4 and UASlacZ as a control and subtracted the endogenous pyr and ths
transcript levels; the domain of ectopic expression supported by twist-Gal4
is significant, as compared with expression supported by zenVRE.Kr-Gal4
and sim-Gal4, and thereby allowed for better resolution of the levels of
ectopic expression.
The lines chosen [pyrline1: UAS-pyr:AMS330(III) and thsline1: UAS-
ths:AMS289.22(III)] exhibit comparable levels of ectopic expression as
assayed by qPCR (see Fig. S4 in the supplementary material) and support
equivalent Eve+ expression when driven by 69B-Gal4 (see Fig. S3D,E in the
supplementary material). In another set of insertions, approximately twice
as much ectopic ths was supported, relative to the levels of pyr (see Fig. S4
in the supplementary material, thsline2 and pyrline2); nevertheless, the same
results were obtained with this other set of lines in the zenVRE.Kr-Gal4-
driven rescue experiments (data not shown). Therefore, we contend that the
ability of pyr alone to support the migration of mesoderm cells at a distance
is not due to differences in expression levels resulting from positional effects
on transgene expression.
Immunohistochemistry, in situ hybridization and sectioning
The following antibodies were used: guinea pig anti-Twist (1:200; from M.
Levine, UC Berkeley, CA, USA), mouse anti-dpERK (1:200; Sigma), rabbit
anti-β-galactosidase (1:200; Molecular Probes), rabbit anti-Eve (1:400; from
M. Frasch) and monoclonal 2A12 (1:3; Developmental Studies Hybridoma
Bank). In situ hybridization (Kosman et al., 2004; Lehmann and Tautz, 1994),
double antibody plus in situ hybridization detection of protein and transcript
levels (Frasch, 1995), and staining of tracheal branches using 2A12 antibody
(Sutherland et al., 1996) were conducted as previously described.
For sectioning, embryos were sorted for appropriate stage and genotype
(i.e. using balancer chromosomes containing reporters), and embedded in
acetone-Araldite (Electron Microscopy Sciences) as described (Leptin and
Grunewald, 1990). Sections (10 μm) were cut using a Historange 2218
microtome.
Because variability is present in the Df(2R)BSC25 mutant background, a
system of quantitation of mutant phenotype was devised. We scored
mesoderm spreading phenotypes in the deficiency and the ectopically
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expressing lines (see Figs S5 and S6 in the supplementary material).
Clumping was used as a measure of the ability of ligands to attract cells to
the ventral midline; the multilayer phenotype was scored by assessing the
ability of ligands to attract cells to the dorsal-most ectoderm.
RESULTS
pyr and ths are dynamically expressed within
Drosophila embryos
It is likely that Pyr and Ths are ligands for the Htl FGF receptor, as
these genes are expressed near sites of Htl expression (Stathopoulos
et al., 2004). During gastrulation, pyr and ths are expressed in distinct
domains within the ectoderm at the surface of the embryo (see Fig.
1A-C). Early in development, ths is expressed in ventral regions (Fig.
1F,G) and pyr is expressed in dorsal regions (Fig. 1D,E). Once
invagination is complete and all mesoderm cells have entered the
interior of the embryo, these cells proceed to migrate along the inner
ectodermal surface, forming a monolayer. Activation of the FGFR Htl
is thought to trigger the spreading of the mesoderm across the
underlying ectoderm (Fig. 1A). The dynamic expression domains of
the ligands suggested a possible mechanism by which directional
information could be imparted to the mesoderm cells moving beneath,
causing these cells to move in the dorsal direction.
Ligand choice and expression domain are
important for FGF signaling
To determine whether the distinct domains of ligand expression are
important for proper mesoderm migration, we altered their expression
domains and assayed effects on mesoderm spreading. Using the 69B-
Gal4 driver, the bnl, pyr and ths FGF-encoding genes were ectopically
expressed throughout the entire ectoderm (Fig. 1H-M). For pyr and
ths, several transgenic lines were first compared with the control for
positional effects that might influence the levels of gene expression,
and a set of lines was chosen that exhibited comparable levels of
ectopic expression by Gal4 as assayed by qPCR (see Fig. S4 in the
supplementary material). Ectopic expression of Pyr throughout the
ectoderm resulted in mesoderm migration defects (Fig. 1J,K; n=9).
The pyr ectopic expression defect was specific; mesoderm spreading
occurred, but a cell monolayer was not formed (Fig. 1K). By contrast,
ectopic expression of Bnl or Ths in the same manner had little to no
effect on mesoderm monolayer formation (Fig. 1G,I and Fig. 1L,M;
n=6 and n=10, respectively).
The MAPK pathway is activated in migrating mesodermal cells as
a result of FGFR receptor tyrosine kinase activation, and leads to dual
phosphorylation of MAPK [also known as ERK (Gabay et al., 1997)
and Rolled – FlyBase]. A monoclonal antibody that recognizes this
activated form of MAPK (dpERK) can be used to monitor activation
of this pathway within cells. dpERK staining is observed within
gastrulating embryos at the leading edge of the migrating mesoderm
cells (see Fig. S1A in the supplementary material), but is lost in the
absence of Htl activation (Michelson et al., 1998; Stathopoulos et al.,
2004). In embryos ectopically expressing pyr or ths via twist-Gal4,
which supports their expression throughout the mesoderm, dpERK is
ectopically expressed throughout all mesoderm cells (see Fig. S1C,E
in the supplementary material) (Stathopoulos et al., 2004). However,
when the 69B-Gal4 driver was used to ectopically express pyr or ths,
only the ectopic expression of pyr supported ectopic activation of
ERK throughout the entire mesoderm (compare Fig. S1D with Fig.
S1F in the supplementary material). Ectopic expression of bnl had no
effect: dpERK remained localized at the leading edge of the migrating
mesoderm [compare Fig. S1B with Fig. S1A (see arrowheads) in the
supplementary material]. Depending on where the ligands were
expressed, differences in the capacity of Pyr versus Ths to activate
signaling were observed, whereas Bnl had no effect. Furthermore, the
ability of these ligands to support ectopic dpERK expression was
found to correlate with the inhibition of mesoderm migration (see Fig.
1; data not shown).
We then assayed the ability of Pyr and Ths to influence trachea
formation, a function that is supported by Bnl-Btl. Ectopic
expression of bnl via 69B-Gal4 leads to a substantial increase in
tracheal branching (compare Fig. S2B with Fig. S2A in the
supplementary material) (Sutherland et al., 1996). However, no such
effect on the trachea was observed upon ectopic expression of pyr
or ths (see Fig. S2C,D in the supplementary material), suggesting
that neither Pyr nor Ths can activate the Btl FGFR.
Isolation and initial characterization of pyr and
ths single mutants
Mesoderm spreading defects are observed in htl mutants and in a
deficiency mutant, Df(2R)BSC25, that removes both pyr and ths
(Fig. 2A) (Beiman et al., 1996; Gisselbrecht et al., 1996;
Stathopoulos et al., 2004). We sought to test further the requirement
for Pyr or Ths in activation of the Htl FGFR by analysis of single-
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Fig. 1. Dynamic expression patterns of pyr and
ths regulate mesoderm migration. (A,B,D-M)
Drosophila embryo cross-sections; (A-C,D,F,H,J,L)
stage 8 embryos; (E,G,I,K,M) stage 9/10 embryos.
(C) Whole-mount embryo oriented with anterior to
the left and dorsal up. (A) Schematic representation
of a stage 8 embryo in cross-section depicting
expression patterns of pyr (blue) and ths (red).
(B,C) During gastrulation, pyr (blue) and ths (red)
are expressed in distinct domains of the neurogenic
ectoderm at the surface of the developing embryo,
concurrent with spreading of mesoderm cells
within the interior of the embryo.
(D-G) Endogeneous pyr (D,E) and ths (F,G)
expression patterns (blue). (H-M) Ectopic expression
of bnl (H,I), pyr (J,K), ths (L,M) in the ectoderm
using the 69B-Gal4 driver (blue).
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mutant phenotypes. First, we identified two PiggyBac insertions
located in proximity to pyr and ths (see Fig. 2A). The line containing
the pyr insertion, pyr02915, is zygotically lethal, whereas the line
containing the ths insertion, ths02026, is only semi-lethal [i.e.
homozygous flies are obtained at very low frequencies (~0.5%) and
are short-lived]. Each insertion disrupts expression of the respective
gene, and we detect no effect on expression of the other ligand (see
Fig. 2E,G, compare with Fig. 2A-C). As phenotypes associated with
insertions can vary, we chose to identify true null alleles.
Deletions of the entire pyr or ths coding sequences were created
(see Fig. 2A and Materials and methods). Because pyr and ths are
linked, deletions resulting from mobilization of the insertion P10004
had the potential to remove either ths or pyr sequences. Through
several rounds of male-specific recombination screening, we were
able to identify a deletion that removes the ths gene in its entirety,
which we named Df(2R)ths238. The entire ths coding sequence, as
well as ten proximal genes, are absent, yet the entire pyr locus remains
intact. Using excision-based screening with the same P9.1.2 insertion,
we obtained a deletion that removes sequence upstream of ths,
including the entire pyr gene and five proximal genes, which we
named Df(2R)pyr36.
Complementation tests were conducted to determine genetic
interactions between our allelic series of pyr and ths mutants. We
believe that the pyr02915 allele represents a pyr null, as no expression
of pyr was detected at any time-point examined. It is unclear whether
the ths02026 allele represents a ths null, as expression could be detected
in the visceral mesoderm at later stages (data not shown). Df(2R)pyr36
and Df(2R)ths238 represent null alleles of pyr and ths, respectively,
because the entire coding region of each gene is absent; however, of
note is the fact that other genes are also removed by these ~100 kb
deletions (see Materials and methods for details). This allelic
series (i.e. PiggyBac insertions: weak alleles; Df(2R)pyr36 and
Df(2R)ths238 deficiencies: strong alleles; Df(2R)BSC25 deficiency:
double mutant; see Fig. 2A) provided the first opportunity to analyze
transheterozygous combinations in order to gain insights into pyr and
ths single-mutant phenotypes. In both pyr and ths single mutants, the
mesoderm spreading was aberrant (Fig. 3G-J, compare with Fig.
3A,B). The mesoderm was multilayered and a monolayer rarely
formed. However, neither mutant exhibited a phenotype as severe as
that of the Df(2R)BSC25 or htl mutants (Fig. 3C-F), suggesting a role
for both Pyr and Ths in guiding mesoderm spreading.
Importance of positional information in the
function of ligands during mesoderm spreading
To determine whether the localized expression of each ligand is
important for its function, we took an ectopic expression approach
using Gal4 to promote expression of a given ligand in the pyr and
ths double-mutant background. Df(2R)BSC25 removes both pyr and
ths, and 16 other genes, none of which has known embryonic
phenotypes (Fig. 2A) (Stathopoulos et al., 2004). The sim-Gal4
driver (Xiao et al., 1996) delivers ligands at the ventral midline
where single-minded (sim) is normally expressed (see Fig. 4F).
Alternatively, the zenVRE.Kr-Gal4 driver can be used to deliver
ligands to the dorsal domain of the ectoderm within the lower half
of gastrulating embryos (see Fig. 4K) (Frasch, 1995).
When the sim-Gal4 driver was used to express either pyr or ths in
the Df(2R)BSC25 mutant background (Fig. 4F), no rescue of
mesoderm spreading was observed (Fig. 4G,H). In fact, clumps of
mesoderm cells were observed overlying the site of Pyr ectopic
expression, suggesting that this ligand had attracted mesoderm cells
to this position (Fig. 4G). This phenotype appeared to be more
severe than that of Df(2R)BSC25 mutants (Fig. 4G,H, compare with
Fig. 4B,C; see Fig. S5 in the supplementary material; P<0.01).
Ectopic expression of ths in this manner also had a weak effect, as
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Fig. 2. Summary of pyr and ths single-mutant
isolation: genetic alleles and expression
analysis. (A) The genomic region containing the
Drosophila pyr and ths loci, and P-element/PiggyBac
insertions and deficiencies identified in this area.
Df(2R)BSC25 deletes ~220 kb (Stathopoulos et al.,
2004). P9.1.2 deletes ~500 bp located ~400 bp
upstream of the ths promoter, and was achieved
through a male-specific recombination screen using
the P10004 insertion. Df(2R)ths238 deletes ~100 kb
including the entire ths coding sequence.
Df(2R)pyr36 removes ~100 kb, including the entire
pyr coding sequence. (B-G) Double in situ
hybridization using riboprobes to detect expression
of both pyr (blue) and ths (red) transcripts within
embryos at stage 10. Embryos are oriented with
anterior to the left and dorsal up. Co-expression
patterns are depicted in wild-type embryos (B-D). In
pyr02915 (E) and Df(2R)pyr36 (F) mutant embryos, no
pyr expression is detected, yet ths expression appears
normal. In ths02026 mutant embryos, no ths
expression is detected, yet the pyr expression domain
appears normal (G).
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cells tended to pool at the ventral midline (Fig. 4H), but this effect
was not supported by statistical significance as the Df(2R)BSC25
mutants themselves exhibit variability (Fig. 4B,C and see Fig. S5 in
the supplementary material).
Different results were obtained using the zenVRE.Kr-Gal4 driver.
In this case, ectopic expression of either pyr or ths did appear sufficient
to direct mesoderm cells toward dorsal regions of the ectoderm in the
lower ventral half of Df(2R)BSC25 mutant embryos (Fig. 4L,M; n=17
and n=19, respectively), within the domain of ectopic expression
supported by the driver (see Fig. 4K). In Df(2R)BSC25 mutant
embryos, some spreading toward dorsal regions was observed in only
28% of the embryos examined (n=10 of 36 embryos scored in total)
(Fig. 4B and see Fig. S5 in the supplementary material); therefore, this
‘rescue’ in the lower half of the embryos by pyr and ths is significant
(see Figs S5 and S6 in the supplementary material). Surprisingly,
however, ectopic expression of pyr in this manner was also capable of
directing the movement of mesoderm cells in the top half of embryos,
at a distance from the source of pyr expression supported by
zenVRE.Kr-Gal4. For ths ectopic expression, the effect on the top half
was not as strong and exhibited more variability (see Figs S5 and S6
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Fig. 3. Pyr and Ths are both required for normal mesoderm spreading. Drosophila embryos were stained with anti-Twist antibody and
sectioned as described (see Materials and methods). (A,B) Wild-type embryos; (C,D) htlAB42 mutant; (E,F) Df(2R)BSC25 mutant, which lacks both pyr
and ths; (G,H) pyr single mutant (pyr02915/pyr02915); (I,J) ths single mutant [Df(2R)ths238/Df(2R)ths238]. (A,B) In wild-type embryos at stage 8, the
invaginated tube collapses and the mesodermal cells start migrating (A). At stage 9/10, the spreading of the mesoderm is complete, resulting in the
formation of a single layer along the internal surface of the ectoderm (B). (C-J) In mutants, the invaginated tube appears to have collapsed normally
at stage 8 (C,E,G,I), but the mesoderm cells exhibit spreading defects that present as a multilayered phenotype at stage 9-10 (D,F,H,J). Cells do not
appear to migrate toward dorsal regions and a monolayer is not formed.
Fig. 4. The specific expression domain of pyr is required for normal mesoderm spreading. (B,C,G,H,L,M) Drosophila embryos stained with
anti-Twist antibody (brown) to detect mesoderm cells and hybridized with the specified riboprobes by in situ hybridization to detect transcripts
(blue); the percentage of embryos exhibiting the mutant phenotype shown is indicated. (D,E,I,J,N,O) Embryos stained with anti-dpERK antibody.
Cross-section views are of stage 9/10 embryos. (A) Schematic of a Df(2R)BSC25 mutant embryo in cross-section; no ectopic expression.
(B,C) Variation in the phenotype of the Df(2R)BSC25 mutant background. Often, spreading can occur, but monolayer formation is defective (B).
Alternatively, neither spreading nor monolayer formation occurs (C). (D) dpERK staining is observed in the leading edge in the wild-type embryo (see
arrowhead) (Gabay et al., 1997). (E) dpERK staining is absent in Df(2R)BSC25 embryos (Stathopoulos et al., 2004). (F) Schematic of ectopic
expression of either ligand (pyr or ths) in the ventral midline of Df(2R)BSC25 mutants using the sim-Gal4 driver (Xiao et al., 1996). (G-J) Ectopic
expression of pyr (G,I) or ths (H,J) in the ventral midline using sim-Gal4 in the Df(2R)BSC25 mutant background. (K) Schematic of ectopic expression
of either ligand within the dorsal ectoderm of Df(2R)BSC25 mutants using the zenVRE.Kr-Gal4 driver (Frasch, 1995). (L-O) Ectopic expression of pyr
(L,N) or ths (M,O) in the dorsal-lateral region of the ectoderm using zenVRE.Kr-Gal4 in the Df(2R)BSC25 mutant background. D
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in the supplementary material). In Df(2R)BSC25, as well as in htlAB42
mutants, such a ‘mixed’ phenotype was not typical, as both top and
bottom halves of the embryo exhibited similar phenotypes (see Fig.
4L,M, compare with Fig. 4C).
Collectively, these results suggest that localized pyr expression is
important to support mesoderm spreading, as zenVRE.Kr-Gal4 is
able to promote spreading, whereas sim-Gal4 is not, and also suggest
the hypothesis that Pyr protein can function at a distance, whereas
Ths functions more locally. To test this, embryos were assayed for
dpERK activity (Fig. 4D-O). Both pyr and ths expression through
sim-Gal4 was able to support dpERK activation (Fig. 4I,J).
Therefore, the weaker effect of ths is unlikely to be due to an
inability to activate the receptor in this domain. Moreover, pyr
expression through zenVRE.Kr-Gal4 supported strong activation of
dpERK throughout the lower half of the embryos (Fig. 4N), whereas
the effect of ectopic expression of ths in this same domain was more
limited (Fig. 4O). Both pyr and ths expression supported dpERK
activation at the leading edge of mesoderm cells in the top half of
embryos (Fig. 4N,O). Mesoderm cells in the top half of the embryo
are able to receive both Pyr and Ths signals, but only a subset of the
cells migrates toward the dorsal ectoderm in response to Ths (see
Discussion).
FGF ligand specificity during mesoderm
differentiation
After mesoderm cell spreading has been completed, both Pyr and
Ths are expressed in regions of the dorsal ectoderm that abut a
subset of the mesoderm cells (Fig. 2D and see Fig. S3A,B in the
supplementary material). pyr is present in more-dorsal regions of
the ectoderm, overlying sites of dorsal mesoderm specification;
limited expression of ths is also seen in this same region (Fig. 2D).
The mesoderm cells that come into contact with the dorsal
ectoderm receive an inductive signal from Decapentaplegic (Dpp),
a Drosophila TGFβ homolog (reviewed by Frasch, 1999).
Thereby, expression of genes such as even skipped (eve) and
tinman, which are required for the differentiation of cardiac and
pericardial tissues, depend on Dpp as well as on Htl-dependent
FGF signaling.
We sought to define the role of each ligand in the specification of
dorsal mesoderm cell lineages within germ-band elongated embryos.
Normally, Eve is expressed within 12 hemisegments. In pyr single
mutants, often only a few hemisegments exhibited Eve expression
(Fig. 5D,E, compare with Fig. 5A), whereas within ths single-mutant
embryos, only subtle defects in Eve+ cell specification were observed
(Fig. 5G,H, compare with Fig. 5A). The pyr mutant phenotype was
much stronger than the phenotype exhibited by ths single mutants at
all stages examined, and even when comparisons were made between
the weakest pyr allele (pyr02915) and the strongest ths allele
[Df(2R)ths238] (Fig. 5C,F, compare with Fig. 5I). Moreover, the
phenotype of Df(2R)pyr36 was consistently stronger than that of
pyr02915, suggesting that either pyr02915 is not a null allele or that ths
gene function also supports Eve+ cell specification. Although Pyr has
the more dominant role, Ths probably also plays a role in supporting
Eve expression because the Df(2R)BSC25 mutant phenotype is more
severe than that of Df(2R)pyr36 mutants. No Eve+ cells are present
within the dorsal mesoderm of Df(2R)BSC25 mutants, a phenotype
similar to that of htl mutants (Fig. 6B) (Stathopoulos et al., 2004).
To investigate the roles of Pyr and Ths in controlling cell
differentiation, which might differ from their roles during cell
migration, we focused on how ectopic expression of these ligands
affects specification of Eve+ cells within the dorsal mesoderm of the
embryo. We have demonstrated previously that when Ths is
ectopically expressed in the ectoderm using the 69B-Gal4 driver,
ectopic Eve+ cells result; this is similar to the phenotype observed
when constitutively activated Htl is ectopically expressed in the
same manner (see Fig. S3E in the supplementary material)
(Stathopoulos et al., 2004). We found that ectopic expression of Pyr
driven by 69B-Gal4 also increases the number of Eve+ cells (see Fig.
S3D in the supplementary material). Normally, three to four Eve+
cells are specified in 12 hemisegments (see Fig. S3C in the
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Fig. 5. The Pyr FGF ligand is necessary for the differentiation of dorsal mesoderm cell lineages. Drosophila embryos were stained with an anti-
Eve antibody to examine specification of dorsal mesoderm lineages. Depicted are wild-type embryos at stage 11 (A) and stage 14 (C); Df(2R)BSC25
mutant embryos, which lack both pyr and ths genes, at stage 11 (B); pyr single mutants at stage 11 (D,E) and stage 14 (F); and ths single mutants at
stage 11 (G,H) and stage 14 (I). The insets display Eve+ cell clusters at 10 magnification. (A,C) In wild-type embryos at stage 11 (A), there are 11
independent clusters of three Eve+ cells each within the dorsal somatic mesoderm. At stage 14 (C), these join to form a continuous row of heart
progenitors. (B) Eve+ clusters are absent from the dorsal mesoderm of Df(2R)BSC25 mutant embryos. (D-F) In both the weakest (pyr02915/pyr02915) and
the strongest [Df(2R)pyr36/Df(2R)pyr36] alleles of pyr single mutants (D and E, respectively), the number of Eve+ clusters is significantly reduced,
resulting in gaps within the row of heart progenitors at stage 14 (F). (G-I) By contrast, within ths mutant embryos at stage 11, when either a weak
mutant [Df(2R)ths238/ths02026] or the strongest alleles [Df(2R)ths238/Df(2R)ths238] are examined (G and H, respectively), there are only subtle effects
on Eve+ cell specification (see inset; often two Eve+ cells are present instead of three). At later stages, defects are more apparent (I).
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supplementary material). In the presence of excess levels of Pyr or
Ths, ~6-15 cells were specified and Eve expression was expanded
to 14 hemisegments (compare Fig. S3C with Fig. S3D in the
supplementary material). When activated Ras is ectopically
expressed in the ectoderm, a similar increase in the number of Eve+
cells is observed (Carmena et al., 1998).
Next, we compared the ability of pyr, ths or bnl to rescue Eve+
expression in the Df(2R)BSC25 mutant background under conditions
of equivalent expression. Either Pyr or Ths was able to support Eve+
expression within dorsal mesoderm cells within Df(2R)BSC25
mutants when expressed using 69B-Gal4 (‘full rescue’; Fig. 6D,E,
compare with Fig. 6B) or zenVRE.Kr-Gal4 (‘partial rescue’; Fig.
6G,H, compare with Fig. 6B) drivers. Similar expression of Bnl failed
to support the specification of any Eve+ cells (Fig. 6F,I). In addition,
when expressed at the ventral midline using sim-Gal4, Bnl, Pyr and
Ths all failed to support Eve expression (see Fig. 6C; data not shown).
In summary, these results suggest that FGF receptors exhibit ligand-
binding preferences, and that the ligands must be expressed in
proximity to the Htl FGFR for activation to occur.
DISCUSSION
The experiments outlined above demonstrate that the Drosophila
FGFs Pyr, Ths and Bnl have different functions and that the
activation of FGF receptors by specific ligands affects particular
biological processes. Examination of an allelic series of pyr and ths
mutants suggests that pyr and ths are not redundant in function: both
influence mesoderm spreading, whereas pyr is the dominant player
controlling Eve+ cell specification within the dorsal mesoderm (Figs
3 and 5). We have demonstrated previously that ectopic expression
of ths by twist-Gal4 and 69B-Gal4 in the Df(2R)BSC25 mutant
background can support Htl FGFR activation (Stathopoulos et al.,
2004). However, in this study, we assayed whether the expression
supported in distinct domains would support Htl activation. By a
series of ‘rescue’ experiments, through ectopic expression of one
ligand in the Df(2R)BSC25 mutant background, we obtained
evidence that localized expression of the ligands is important for
proper mesoderm spreading. We find, surprisingly, that the ligands
exhibit differences in their functional range of action (Fig. 4). In
addition, using this same approach, we find that either Pyr or Ths
can support Eve+ cell specification within the dorsal mesoderm, but
that Bnl cannot (Fig. 6). Collectively, these data suggest that the Pyr
and Ths FGFs function as ligands for the Htl FGFR and that
specificity of FGF-FGFR interactions exists in Drosophila.
Specificity of FGFR activation: only three FGF-FGFR
combinations function in Drosophila
Our results demonstrate that both Pyr and Ths FGF ligands can
activate the Htl FGFR, whereas only the Bnl FGF ligand can activate
the Btl FGFR (Fig. 6 and see Fig. S2 in the supplementary material).
Specificity of FGFR activation was observed: pyr or ths, but not bnl,
expression is able to activate Htl to affect expression of Eve, and bnl,
but neither pyr nor ths, is able to support tracheal specification. No
evidence was obtained that other cross-interactions occur (i.e. Pyr-
Btl, Ths-Btl or Bnl-Htl), which demonstrates that Gal4-mediated
ectopic expression does not simply ‘swamp the system’. This
experimental approach also ‘levels the playing field’, as expression
of each ligand is driven at the same time and place and presumably
at similar levels. We conclude that only three FGF-FGFR
combinations function in Drosophila (i.e. Pyr-Htl, Ths-Htl and Bnl-
Btl), which supports the idea that FGFRs exhibit ligand-binding
preferences. Previous studies have investigated FGF signaling
specificity by analyzing the ability of other receptor tyrosine kinases
to support cell migration or by activating particular intracellular
signaling pathways to examine which are required to effect FGFR-
dependent cell migration versus cell differentiation (Dossenbach et
al., 2001; Wilson et al., 2005). In this work, we analyzed the
specificity of FGF ligand-receptor interactions and how they
contribute to particular developmental processes.
Different FGF ligand activities regulate particular
developmental processes
When ligand expression is supported by twist-Gal4, Htl FGFRs
presumably become saturated because dpERK is ectopically
activated in all cells and spreading is negatively affected (see Fig.
S1 in the supplementary material). One explanation for why this
might affect mesoderm cell spreading is that these FGF-saturated
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Fig. 6. Pyr and Ths, but not Bnl,
can support Htl activation to
effect expression of Eve within
dorsal mesoderm lineages.
Drosophila embryos oriented with
anterior to the left and dorsal up.
Ectopic expression of UAS-pyr, UAS-
ths or UAS-bnl in a Df(2R)BSC25
mutant background, which lacks the
endogenous pyr and ths genes, was
achieved using various Gal4 drivers
that support expression in different
domains of the ectoderm. Depicted
are lateral views of stage 11
embryos stained using an anti-Eve
antibody (green) and by in situ
hybridization with riboprobes to
detect pyr (D,G), ths (A-C,E,H) or bnl
(F,I) transcript levels (red). (A) Endogeneous expression of ths in wild-type embryos. Eve+ cells are present in 12 hemisegments. (B) ths expression in
Df(2R)BSC25 mutant embryos. No dorsal mesoderm-derived Eve+ cells are present. Eve staining is detected only in the central nervous system,
expression that is FGF-signaling independent. (C) Expression of ths in the ventral midline using sim-Gal4 does not support expression of Eve in a
homozygous Df(2R)BSC25 mutant background. (D-F) Ectopic expression of pyr (D) or ths (E) in the ectoderm using 69B-Gal4 does support expression of
Eve+ in a homozygous Df(2R)BSC25 mutant background, whereas bnl (F) does not. (G-I) Ectopic expression of pyr (G) or ths (H) in the ectoderm using
zenVRE.Kr-Gal4 also supports expression of Eve+ in a homozygous Df(2R)BSC25 mutant background, whereas again bnl (I) does not.
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mesoderm cells may no longer be competent to respond to
endogenous ligands that provide directional cues. Recently, we have
shown that movement of the mesoderm cells during gastrulation is
in fact directional (McMahon et al., 2008). Pyr and Ths ligands are
differentially expressed during gastrulation and this might provide
the necessary positional information required to direct migration of
the mesoderm (see Fig. 7A).
We propose that Pyr and Ths have different activities that fulfil
aspects of FGFR activation required to support cell migration
(Fig. 7A). Ectopic expression of Pyr within the ectoderm
negatively affects mesoderm spreading (Fig. 1H-M), which
suggests that the refined expression domain of pyr within cells of
the dorsal ectoderm is normally required to guide the mesoderm
cells toward dorsal regions. However, even though ectopic
expression of ths in the ectoderm has no effect on mesoderm
spreading, ths mutants also exhibit defects in mesoderm
spreading, demonstrating that both genes are required, perhaps to
control different aspects of the migration. Our ‘rescue’
experiments using the zenVRE.Kr-Gal4 driver support the view
that Pyr has a longer functional range than Ths (Fig. 4N,O). These
differences in range of function might correlate with different
diffusion capabilities, but an alternative explanation is that the
ligands activate the receptor with different affinities. Additional
experiments will be necessary to distinguish their exact functions
and to uncover the molecular basis for the differential functions
of Pyr and Ths; we suggest that in vivo imaging and quantitative
analysis (McMahon et al., 2008) of single-mutant phenotypes will
provide insights.
With regard to the FGF-dependent cell differentiation, our
‘rescue’ experiments suggest that ectopic expression of either Pyr or
Ths is sufficient to support Eve+ cell specification (Fig. 6D,E). The
reason why loss of ths has less of an effect on Eve+ cell specification
is most likely because pyr is prominently expressed in the vicinity
of the future Eve+ cells; normally, Pyr supports this function, but Ths
can support this activity if presented at sufficient levels within the
correct domain. Furthermore, we propose that FGF signaling might
not play an instructive role in supporting eve expression (Fig. 7B).
Other signaling pathways already provide positional information
required for the specification of Eve+ cells; FGF signaling pathway
activation might simply serve a permissive role, and in this context
either ligand would suffice.
Conclusion: implications for vertebrate biology?
We have used Drosophila to study FGF signaling and determine
why multiple ligands are utilized to activate the same receptor. It
will be informative to obtain additional insights into how these
ligands differ in their activities. The expression domains of the
ligands do confer information that is important for controlling
developmental processes, but their individual protein sequences
also impart differential functionality. For instance, the ligands
might exhibit different affinities for specific HSPGs that influence
their range of diffusion, or the proteins themselves may have
different stabilities. Future experiments will also define the FGF
ligand preferences that exist to support FGF signaling at later stages
of development.
At least 15 human genetic diseases result from mutations within
FGFR genes and each disease is caused by a different mutation
shown to affect receptor activation (Chen and Deng, 2005). Several
mutations in FGFR lead to an expansion of FGF ligand-binding
preference (Ornitz, 2005); however, it is still not clear why different
mutations yield different syndromes. Continuing this work in order
to understand how different FGF ligands activate the same receptor
to effect different outcomes is an important goal, as this may provide
insights into why different mutations in the same FGFR lead to
various dysplasias and diseases (Wilkie, 2005).
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